The government effort to combat rampant abuse of prescription opioids by primarily addressing the supply side continues. Like many states, CA has a Prescription Drug Monitoring System (PDMP) in place. This tool should enable physicians and pharmacists to view what controlled substances were previously prescribed for a particular patient and help in making clinical decisions. However, the experience clinicians have with the system leaves much to be desired.
Recently passed legislation (SB 809) mandates that all prescribers and dispensers of controlled substances will subscribe, for a fee, to this service as of January 1, 2016. However, the mandate does not extend to actual USE of the system. One may ask what good is it to mandate that the prescribers subscribe to a monitoring system that they can choose to ignore when making prescribing decisions. The Broken Cure, an investigative report by Jason Smith recently published in The Press Tribune, outlines some of the shortcomings of the California system.
It is ironic that the state that is home to Google, Cisco, HP, and other Silicon Valley information technology giants appears to be unable to manage simple data collection and distribution.
Read The Broken Cure here: https://medium.com/human-parts/the-broken-cure-64dcdc00db9